Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACEM: Montelukast + Low-Dose Budesonide vs Medium-Dose Budesonide in Elderly Asthma
NCT01147510Phase 4Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Jul 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of montelukast in asthma, sponsored by Ajou University School of Medicine. Primary endpoint: Rate of patients reaching well controlled asthma status at 12 weeks. Started Jul 2010; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01147510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01147510.